[Corrigendum] Hsa‑circRNA‑G004213 promotes cisplatin sensitivity by regulating miR‑513b‑5p/PRPF39 in liver cancer
Affiliations: Department of Gastroenterology, Clinical Medical College and The First Affiliated Hospital of Chengdu Medical College, Chengdu, Sichuan 610000, P.R. China
- Published online on: August 11, 2021 https://doi.org/10.3892/mmr.2021.12359
- Article Number: 720
Copyright : © Qin et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].
This article is mentioned in:
Mol Med Rep 23: Article no. [Related article:] 421, 2021; DOI: 10.3892/mmr.2021.12060
Following the publication of the above article, the authors have realized that, on p. 8, some of the supplementary data were cited incorrectly in the main text. In the right-hand column, second paragraph, the sentence beginning on line 5 should have read as follows (changed text is highlighted in bold): “Meanwhile, the expression of miR-513b-5p in tumor tissues was decreased and the expression of PRPF39 was increased in tumor tissues with knockout of circ-G004213 (Fig. S3D and E).” (i.e., the reference to Fig. S3C and D was incorrect.)
The authors regret their oversight in failing to correct the inaccurate citation of the data in the paper, are grateful to the Editor for allowing them the opportunity to publish this Corrigendum, and apologize to the readership for any inconvenience caused.